A carregar...

Recombinant human adenovirus-p53 improves the outcome of mid-late stage pancreatic cancer via arterial infusion

The present study aimed to investigate the therapeutic efficacy and clinical value of recombinant human adenovirus-p53 (rAd-p53) perfusion via the pancreatic artery for the treatment of mid-late stage pancreatic cancer. rAd-p53 (2×10(12) virus particles) in 6 ml normal saline was pushed (intravenous...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Mo, Jinggang, Lin, Meihua, He, Bin, Tan, Kai, Jin, Chong, Jiang, Hao, Pan, Xuefeng, Lin, Weidong
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5696714/
https://ncbi.nlm.nih.gov/pubmed/29181104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.7058
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!